A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

Medientyp: E-Artikel
Titel: A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study
Beteiligte: de Gonzalo-Calvo, David; Molinero, Marta; Benítez, Iván D.; Perez-Pons, Manel; García-Mateo, Nadia; Ortega, Alicia; Postigo, Tamara; García-Hidalgo, María C.; Belmonte, Thalia; Rodríguez-Muñoz, Carlos; González, Jessica; Torres, Gerard; Gort-Paniello, Clara; Moncusí-Moix, Anna; Estella, Ángel; Tamayo Lomas, Luis; Martínez de la Gándara, Amalia; Socias, Lorenzo; Peñasco, Yhivian; de la Torre, Maria Del Carmen; Bustamante-Munguira, Elena; Gallego Curto, Elena; Martínez Varela, Ignacio; Martin Delgado, María Cruz; [...]
Erschienen: Springer Science and Business Media LLC, 2023
Erschienen in: Respiratory Research
Sprache: Englisch
DOI: 10.1186/s12931-023-02462-x
ISSN: 1465-993X
Entstehung:
Anmerkungen:
Beschreibung: <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>The identification of critically ill COVID-19 patients at risk of fatal outcomes remains a challenge. Here, we first validated candidate microRNAs (miRNAs) as biomarkers for clinical decision-making in critically ill patients. Second, we constructed a blood miRNA classifier for the early prediction of adverse outcomes in the ICU.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>This was a multicenter, observational and retrospective/prospective study including 503 critically ill patients admitted to the ICU from 19 hospitals. qPCR assays were performed in plasma samples collected within the first 48 h upon admission. A 16-miRNA panel was designed based on recently published data from our group.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Nine miRNAs were validated as biomarkers of all-cause in-ICU mortality in the independent cohort of critically ill patients (FDR < 0.05). Cox regression analysis revealed that low expression levels of eight miRNAs were associated with a higher risk of death (HR from 1.56 to 2.61). LASSO regression for variable selection was used to construct a miRNA classifier. A 4-blood miRNA signature composed of miR-16-5p, miR-192-5p, miR-323a-3p and miR-451a predicts the risk of all-cause in-ICU mortality (HR 2.5). Kaplan‒Meier analysis confirmed these findings. The miRNA signature provides a significant increase in the prognostic capacity of conventional scores, APACHE-II (C-index 0.71, DeLong test p-value 0.055) and SOFA (C-index 0.67, DeLong test p-value 0.001), and a risk model based on clinical predictors (C-index 0.74, DeLong test-p-value 0.035). For 28-day and 90-day mortality, the classifier also improved the prognostic value of APACHE-II, SOFA and the clinical model. The association between the classifier and mortality persisted even after multivariable adjustment. The functional analysis reported biological pathways involved in SARS-CoV infection and inflammatory, fibrotic and transcriptional pathways.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>A blood miRNA classifier improves the early prediction of fatal outcomes in critically ill COVID-19 patients.</jats:p> </jats:sec>
Zugangsstatus: Freier Zugang

Nur in Feld suchen:

Zuletzt gesuchte Begriffe: